摘要
脑高灌注综合征最初在颈动脉血运重建术后发现,在急性缺血性脑血管病患者中也有报道,是一种发生率较低却极为危险的并发症,对患者的生命安全造成极为严重的损害。随着医学技术的不断进步、医用材料和医疗技术的不断发展,颈动脉或脑血管的血管内治疗越来越常见,高灌注综合征也不时见诸于临床。文中对脑高灌注综合征的流行病学、发病机制、危险因素、检测手段、预防及治疗措施等方面进行综述,希望对临床应用提供参考。
Cerebral hyperperfusion syndrome( CHS) was first discovered in carotid revascularization and has been reported in patients with acute ischemic cerebrovascular disease. It is a low-risk but extremely dangerous complication. Extremely serious damage to the patient ’s life. With the continuous advancement of science and technology,as well as the continuous development of medical materials and medical technology,carotid or intracranial vascular operation is becoming more and more common,and hyperperfusion syndrome is also seen clinically. Its research progress were reviewed and provide some reference for clinical application.
作者
卢柳西
李长清
LU Liu-xi;LI Chang-qing(The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
出处
《中国临床神经科学》
2019年第1期85-89,共5页
Chinese Journal of Clinical Neurosciences
关键词
脑高灌注综合征
再灌注损伤
缺血性脑血管病
cerebral hyperperfusion syndrome
reperfusion injury
ischemic cerebrovascular disease
作者简介
卢柳西,在读研究生,主治医师,主要从事神经系统常见疾病尤其是脑血管病的诊治研究;通信作者;李长清,E-mail:licq9217@163.com.
